Skip to the content
Know your tech before you buy it. Makers: get listed from $49/mo

Buddy-In

neudive.com

  • iPhone and iPad
  • Android
5.9 Club score Visit neudive.com

What the maker publishes

Clinical evidence
Neudive says exploratory and confirmatory clinical trials were completed and found safety and improvement in Adaptive Behavior Composite score versus control. source
Clinician monitoring
The system records usage, performance, and training progress for clinicians to monitor in real time. source
Founded
2022 source
Headquarters
Daegu, South Korea source
Maker
Neudive says it was founded in 2022 and lists its headquarters in Daegu, South Korea. source
Medical-device certification
Buddy-In received MFDS manufacturing certification as a Class II digital medical device on May 7, 2026. source
Parent reports
Parents receive reports about what their child is learning and changes in social skills over time. source
Personalized scenarios
Mobile scenario-based games and an algorithm-driven structure tailor training to each user's level. source
Prescription
Buddy-In is prescribed by a medical professional following diagnosis and assessment of suitability. source
Purpose
Buddy-In is a digital medical device for social-skills training for children and adolescents aged 10–18 with ASD or Social (Pragmatic) Communication Disorder. source
Support
Neudive lists weekday support hours of 09:00–18:00 and provides a phone number and email address. source
Therapy approach
Buddy-In is based on Cognitive Behavioral Therapy and Social Skills Training. source
Training schedule
The program is designed for 30 sessions over six weeks, five times a week, for about 10 minutes per session. source
Use alongside treatment
Buddy-In is intended to complement, not replace, existing treatment or in-person support. source
Use caution
The maker recommends guardian monitoring and stopping use if discomfort or unusual behavior occurs. source

Checked against the maker's pages on 14 Nov 2026.